Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study
Conclusion PDA-001 infusions were safe and well tolerated in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis patients. No paradoxical worsening of lesion counts was noted with either dose.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Brain | Disability | Headache | Migraine | MRI Scan | Multiple Sclerosis | Neurology | PET Scan | Study | Urinary Tract Infections